Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor Myocarditis.
Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek S, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehman L, Ederhy S, Moslehi J, Salem JE; International ICI-Myocarditis Registry†. Power JR, et al. Among authors: gilstrap l. Circulation. 2021 Nov 2;144(18):1521-1523. doi: 10.1161/CIRCULATIONAHA.121.055816. Epub 2021 Nov 1. Circulation. 2021. PMID: 34723640 Free PMC article. No abstract available.
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis.
Power JR, Alexandre J, Choudhary A, Ozbay B, Hayek SS, Asnani A, Tamura Y, Aras M, Cautela J, Thuny F, Gilstrap L, Arangalage D, Ewer S, Huang S, Deswal A, Palaskas NL, Finke D, Lehmann LH, Ederhy S, Moslehi J, Salem JE; International ICI-Myocarditis Registry. Power JR, et al. Among authors: gilstrap l. Arch Cardiovasc Dis. 2022 May;115(5):315-330. doi: 10.1016/j.acvd.2022.03.003. Epub 2022 Apr 27. Arch Cardiovasc Dis. 2022. PMID: 35595646 Free article.
Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry.
Nowatzke J, Guedeney P, Palaskas N, Lehmann L, Ederhy S, Zhu H, Cautela J, Francis S, Courand PY, Deswal A, Ewer SM, Aras M, Arangalage D, Ghafourian K, Fenioux C, Finke D, Peretto G, Zaha V, Itzhaki Ben Zadok O, Tajiri K, Akhter N, Levenson J, Baldassarre L, Power J, Huang S, Collet JP, Moslehi J, Salem JE; International ICI-myocarditis registry contributors. Nowatzke J, et al. Eur J Cancer. 2022 Dec;177:197-205. doi: 10.1016/j.ejca.2022.07.018. Epub 2022 Aug 24. Eur J Cancer. 2022. PMID: 36030143 Free PMC article.
Opportunities and Challenges of Claims-Based Quality Assessment: The Case of Postdischarge β-Blocker Treatment in Patients With Heart Failure With Reduced Ejection Fraction.
Gilstrap L, Skinner JS, Gladders B, O'Malley AJ, Barnato AE, Tosteson ANA, Austin AM. Gilstrap L, et al. Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e006180. doi: 10.1161/CIRCOUTCOMES.119.006180. Epub 2020 Mar 9. Circ Cardiovasc Qual Outcomes. 2020. PMID: 32148101 Free PMC article.
Unanswered Questions in Contemporary Heart Failure.
Gilstrap LG, Snipelisky D, AbouEzzeddine O, Vader J, Cooper L, Kelley J, Perez A, Varian K, Lala A, Shah M, Stevenson LW. Gilstrap LG, et al. J Card Fail. 2017 Oct;23(10):770-774. doi: 10.1016/j.cardfail.2017.06.009. Epub 2017 Jul 6. J Card Fail. 2017. PMID: 28689765 Free PMC article.
Propensity to match or mismatch patients and therapies?
Stevenson LW, Schneiweiss S, Gilstrap L. Stevenson LW, et al. Among authors: gilstrap l. Eur J Heart Fail. 2018 Feb;20(2):355-358. doi: 10.1002/ejhf.983. Epub 2017 Oct 12. Eur J Heart Fail. 2018. PMID: 29027354 Free article. No abstract available.
257 results